Diagnosis and treatment of laryngopharyngeal reflux disease.
- Author:
Rong ZHAO
1
;
Haibing LIU
Author Information
1. Department of Otolaryngology, the Central Hospital of Chengdu Railway, Chengdu, 610081, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Aged;
Female;
Humans;
Laryngopharyngeal Reflux;
diagnosis;
drug therapy;
physiopathology;
Male;
Middle Aged;
Proton Pump Inhibitors;
therapeutic use;
Young Adult
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2011;25(15):690-691
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the diagnosis and treatment of laryngopharyngeal reflux disease.
METHOD:Patients suspect of laryngopharyngeal reflux disease in our out-patient department from Jan 2008 to Jan 2009 were included in this study. All patients were assessed using the reflux symptom index(RSI) and the reflux finding score(RFS). The positive criteria of RSI was score > 13 and that of RFS was score > 7. Fifty-eight double positive patients accepted omeprazole oral administration. After continuous oral administration for three months, all patients received RSI and RFS assessment again.
RESULT:After treatment, the symptoms of 41 patients were significantly alleviated. In addition, RSI were positive in 41 cases and RFS were positive in 37 cases. Thirty-seven cases were double positive.
CONCLUSION:The RSI and RFS could serve as an effective assessment method and could accurately document treatment efficacy in patients with LPR. Proton pump inhibitor such as omeprazole is an effective treatment for patients with LPR.
